EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Twist Bioscience's enterprise value is $1,602.0 Mil.
Twist Bioscience's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-172.4 Mil. Therefore, Twist Bioscience's EV-to-EBITDA for today is -9.29.
The historical rank and industry rank for Twist Bioscience's EV-to-EBITDA or its related term are showing as below:
TWST'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -75.47 Med: -8.5 Max: -2.01
Current: -9.33
During the past 8 years, the highest EV-to-EBITDA of Twist Bioscience was -2.01. The lowest was -75.47. And the median was -8.50.
TWST's EV-to-EBITDA is ranked worse than 100% of 118
companies
in the Medical Diagnostics & Research industry
Industry Median: 15.53
vs TWST: -9.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-24), Twist Bioscience's stock price is $31.71.
Twist Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.610. Therefore, Twist Bioscience's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Twist Bioscience EV-to-EBITDA Historical Data
The historical data trend for Twist Bioscience's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Twist Bioscience's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Twist Bioscience EV-to-EBITDA Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Twist Bioscience's EV-to-EBITDA falls into.
Twist Bioscience EV-to-EBITDA Calculation
Twist Bioscience's EV-to-EBITDA for today is calculated as:
Twist Bioscience's current Enterprise Value is $1,602.0 Mil.
Twist Bioscience's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-172.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Twist Bioscience's PE Ratio for today is calculated as:
Twist Bioscience's share price for today is $31.71.
Twist Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.610.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Twist Bioscience's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Twist Bioscience (Twist Bioscience) Business Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TWST has been successfully added to your 